美国 · SEC FORM 4
Immuneering Corp
IMRX · Nasdaq · CIK 0001790340 · Healthcare · Biotechnology
内部人信号
2 位买方 · 2 条买入交易行 · $36.0K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ⚠ 角色得分低 · 买入者中职位最高的是：PRESIDENT AND CEO（CEO、董事长和持股 10% 以上的股东得分最低）
- ⚠ Purchase activity is becoming less recent
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: CHIEF SCIENTIFIC OFFICER, PRESIDENT AND CEO. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 42.8
- 42.7
- 42.7
- 42.6
- 42.5
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -13.8%
- 3M
- -23.6%
- 6M
- -28.6%
- 12M
- -39.4%
波动率与流动性
- 波动率
- 102.8%
- Beta
- —
- 平均每日成交额
- USD 2.8M
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- —
- ROE
- -25.6%
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：ROE · 财年截止日：2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 15,492,438
- 上期报告
- 15,550,745
- 日均成交量
- 639,765
- 回补天数
- 24.2
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-23 | Zeskind Benjamin J. | 买入 (P) | Class A Common Stock | 2,400 | USD 4.56 | USD 10,944 | SEC 申报 ↗ |
| 2026-06-15 | Hall Brett Matthew | 买入 (P) | Class A Common Stock | 6,035 | USD 4.15 | USD 25,045 | SEC 申报 ↗ |
| 2026-01-16 | Brakewood Harold Eugene | 买入 (P) | Class A Common Stock | 5,250 | USD 4.76 | USD 24,990 | SEC 申报 ↗ |
| 2026-01-15 | Schall Thomas J. | 买入 (P) | Class A Common Stock | 21,645 | USD 4.67 | USD 101,082 | SEC 申报 ↗ |
| 2026-01-15 | Hall Brett Matthew | 买入 (P) | Class A Common Stock | 2,298 | USD 4.57 | USD 10,502 | SEC 申报 ↗ |
| 2026-01-13 | Neufeld Leah R | 买入 (P) | Class A Common Stock | 2,626 | USD 4.15 | USD 10,898 | SEC 申报 ↗ |
| 2026-01-12 | Feinberg Peter | 买入 (P) | Class A Common Stock | 20,000 | USD 4.35 | USD 87,000 | SEC 申报 ↗ |
| 2025-10-03 | Feinberg Peter | 买入 (P) | Class A Common Stock | 7,500 | USD 6.67 | USD 50,025 | SEC 申报 ↗ |
| 2025-10-01 | Neufeld Leah R | 买入 (P) | Class A Common Stock | 800 | USD 6.38 | USD 5,104 | SEC 申报 ↗ |
| 2025-10-01 | Morales Mallory | 买入 (P) | Class A Common Stock | 300 | USD 6.39 | USD 1,917 | SEC 申报 ↗ |
| 2025-10-01 | Bookman Michael | 买入 (P) | Class A Common Stock | 1,020 | USD 6.83 | USD 6,967 | SEC 申报 ↗ |
| 2025-09-30 | Feinberg Peter | 买入 (P) | Class A Common Stock | 7,500 | USD 7.03 | USD 52,725 | SEC 申报 ↗ |
| 2025-09-29 | Feinberg Peter | 买入 (P) | Class A Common Stock | 5,000 | USD 7.18 | USD 35,900 | SEC 申报 ↗ |
| 2025-07-02 | Neufeld Leah R | 买入 (P) | Class A Common Stock | 700 | USD 3.57 | USD 2,499 | SEC 申报 ↗ |
| 2025-07-02 | HAUSMAN DIANA | 买入 (P) | Class A Common Stock | 5,500 | USD 3.61 | USD 19,860 | SEC 申报 ↗ |
Form 4 申报证据
8 transaction lines in the latest 365-day window; 97 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-23 | Zeskind Benjamin J. | 买入 (P) | Class A Common Stock | 2,400 | USD 4.56 | USD 10,944 | SEC 申报 ↗ |
| 2026-06-15 | Hall Brett Matthew | 买入 (P) | Class A Common Stock | 6,035 | USD 4.15 | USD 25,045 | SEC 申报 ↗ |
| 2026-03-13 | Neufeld Leah R | 奖励／授予 (A) | Class A Common Stock | 3,628 | USD 4.29 | USD 15,564 | SEC 申报 ↗ |
展开近期 Form 4 证据 (8 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-23 | Zeskind Benjamin J. | 买入 (P) | Class A Common Stock | 2,400 | USD 4.56 | USD 10,944 | SEC 申报 ↗ |
| 2026-06-15 | Hall Brett Matthew | 买入 (P) | Class A Common Stock | 6,035 | USD 4.15 | USD 25,045 | SEC 申报 ↗ |
| 2026-03-13 | Neufeld Leah R | 奖励／授予 (A) | Class A Common Stock | 3,628 | USD 4.29 | USD 15,564 | SEC 申报 ↗ |
| 2026-01-16 | Brakewood Harold Eugene | 买入 (P) | Class A Common Stock | 5,250 | USD 4.76 | USD 24,990 | SEC 申报 ↗ |
| 2026-01-15 | Schall Thomas J. | 买入 (P) | Class A Common Stock | 21,645 | USD 4.67 | USD 101,082 | SEC 申报 ↗ |
| 2026-01-15 | Hall Brett Matthew | 买入 (P) | Class A Common Stock | 2,298 | USD 4.57 | USD 10,502 | SEC 申报 ↗ |
| 2026-01-13 | Neufeld Leah R | 买入 (P) | Class A Common Stock | 2,626 | USD 4.15 | USD 10,898 | SEC 申报 ↗ |
| 2026-01-12 | Feinberg Peter | 买入 (P) | Class A Common Stock | 20,000 | USD 4.35 | USD 87,000 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | IMRX |
| CIK | 0001790340 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 97 transaction lines from 2021-08-03 to 2026-06-23 61 P purchase lines · 13 S sale lines · 23 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.